Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chrysos

Showing results (161-170 of 192) with videos related to

Pageof 20
Sort By:
Ebiomedicine|April 4, 2026
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trialEmmanouil Stylianakis, Nikolaos Kakavoulis, Spyros Foutadakis, et al.
Plos One|April 1, 2020
Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in GreeceGiota Touloumi, Natasa Kalpourtzi, Vasileios Papastamopoulos, et al.
Genes|November 16, 2017
Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public HealthDimitrios Paraskevis, Evangelia Kostaki, Panagiotis Gargalianos, et al.
Journal of the International AIDS Society|November 15, 2014
Patterns of drug resistance among newly diagnosed HIV-1 infected patients in Greece during the last decade: the crucial role of transmission networksDimitrios Paraskevis, Assimina Zavitsanou, Emmanouil Magiorkinis, et al.
Infectious Diseases and Therapy|December 19, 2023
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive ProteinKonstantina Iliopoulou, Panagiotis Koufargyris, Sarantia Doulou, et al.
International Journal of Antimicrobial Agents|December 8, 2024
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trialKarolina Akinosoglou, Konstantinos Leventogiannis, Elisavet Tasouli, et al.
Journal De Mycologie Medicale|April 4, 2024
Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica regionLida Politi, Georgia Vrioni, Sofia Hatzianastasiou, et al.
Cell Reports. Medicine|January 3, 2026
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infectionChristos Psarrakis, Nikolaos-Renatos Tziolos, Vicky Matzarakis, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissionsD Paraskevis, E Kostaki, G Magiorkinis, et al.
American Journal of Respiratory and Critical Care Medicine|August 8, 2020
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized TrialEvdoxia Kyriazopoulou, Lydia Liaskou-Antoniou, George Adamis, et al.
Pageof 20

Showing results (161-170 of 192) with videos related to

Sort By:
Pageof 20
Ebiomedicine|April 4, 2026
Molecular pathways driving clarithromycin benefit in community-acquired pneumonia: analysis of the ACCESS randomised trialEmmanouil Stylianakis, Nikolaos Kakavoulis, Spyros Foutadakis, et al.
Plos One|April 1, 2020
Cardiovascular risk factors in HIV infected individuals: Comparison with general adult control population in GreeceGiota Touloumi, Natasa Kalpourtzi, Vasileios Papastamopoulos, et al.
Genes|November 16, 2017
Transmission Dynamics of HIV-1 Drug Resistance among Treatment-Naïve Individuals in Greece: The Added Value of Molecular Epidemiology to Public HealthDimitrios Paraskevis, Evangelia Kostaki, Panagiotis Gargalianos, et al.
Journal of the International AIDS Society|November 15, 2014
Patterns of drug resistance among newly diagnosed HIV-1 infected patients in Greece during the last decade: the crucial role of transmission networksDimitrios Paraskevis, Assimina Zavitsanou, Emmanouil Magiorkinis, et al.
Infectious Diseases and Therapy|December 19, 2023
Developing a Tool for Differentiation Between Bacterial and Viral Respiratory Infections Using Myxovirus Resistance Protein A and C-Reactive ProteinKonstantina Iliopoulou, Panagiotis Koufargyris, Sarantia Doulou, et al.
International Journal of Antimicrobial Agents|December 8, 2024
Clarithromycin for improved clinical outcomes in community-acquired pneumonia: A subgroup analysis of the ACCESS trialKarolina Akinosoglou, Konstantinos Leventogiannis, Elisavet Tasouli, et al.
Journal De Mycologie Medicale|April 4, 2024
Candida auris in Greek healthcare facilities: Active surveillance results on first cases and outbreaks from eleven hospitals within Attica regionLida Politi, Georgia Vrioni, Sofia Hatzianastasiou, et al.
Cell Reports. Medicine|January 3, 2026
A randomized controlled trial of precision bezlotoxumab treatment for Clostridioides difficile infectionChristos Psarrakis, Nikolaos-Renatos Tziolos, Vicky Matzarakis, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|July 10, 2017
Prevalence of drug resistance among HIV-1 treatment-naive patients in Greece during 2003-2015: Transmitted drug resistance is due to onward transmissionsD Paraskevis, E Kostaki, G Magiorkinis, et al.
American Journal of Respiratory and Critical Care Medicine|August 8, 2020
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized TrialEvdoxia Kyriazopoulou, Lydia Liaskou-Antoniou, George Adamis, et al.
Pageof 20